Inhibition of Apoptosis by Amphiregulin via an Insulin‐like Growth Factor‐1 Receptor—Dependent Pathway in Non‐Small Cell Lung Cancer Cell Lines
- 1 December 2003
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1010 (1) , 354-357
- https://doi.org/10.1196/annals.1299.065
Abstract
The reciprocal activation of amphiregulin (AR) and insulin‐like growth factor‐1 (IGF1) pathways has been shown to induce inhibition of serum deprivation apoptosis in non‐small cell lung cancer (NSCLC) cell lines H358 and H322. We demonstrated that AR activated the IGF1 receptor (IGF1‐R), which in turn induced the secretion of AR and IGF1. Transactivation of the IGF1‐R by AR is independent of its binding to EGFR. Thus, AR can inhibit apoptosis in NSCLC cells through an IGF1‐R‐dependent pathway.Keywords
This publication has 4 references indexed in Scilit:
- Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell LinesJournal of Biological Chemistry, 2002
- Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesisJournal of Cellular Physiology, 2000
- Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancerCurrent Opinion in Oncology, 1999
- Molecular abnormalities in lung cancer.Journal of Clinical Oncology, 1998